Skip to content

TuHURA Biosciences, Inc. HURA Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$30.92M-63.3%-$30.05M-75.6%-$29.29M-141%-$24.35M-88.2%-$18.93M+38.7%
$80.68K+0.1%$71.27K-29.4%$66.36K$62.06K$80.63K
$7.8M+185%$6.42M+292%$5.36M$4.01M$2.73M
-$27.3M-120%-$27.63M-140%-$24.67M-$15.48M-$12.39M
$82.26K+2.1%$76.08K+31.4%$69.64K$69.64K$80.58K
-$233.16K+96.8%-$1.34M+77.9%-$2.13M-$7.32M-$7.18M
$27.62M+12.3%$19.93M-33.1%$15.84M$26.28M$24.59M
$1.76M
-$27.39M-98.3%-$27.71M-87.4%-$24.74M-$16.88M-$13.81M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does TuHURA Biosciences, Inc. generate?
TuHURA Biosciences, Inc. (HURA) generated -$27.3M in operating cash flow over the trailing twelve months.
What is TuHURA Biosciences, Inc.'s free cash flow?
After $82.3K of capital expenditures, TuHURA Biosciences, Inc.'s free cash flow was -$27.4M over the trailing twelve months, down 98.3% year over year.
Where does TuHURA Biosciences, Inc.'s cash flow data come from?
Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.